These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 4047447)

  • 1. [Treatment of chronic cerebrovascular insufficiency and chronic obliterating arteriopathy of the lower extremities with buflomedil hydrochloride].
    Salerno L; Sallì L; Pepe S; Curiale B; Allegra G; Scalici G; Salvato F
    Minerva Med; 1985 Sep; 76(36):1611-8. PubMed ID: 4047447
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effect of buflomedil on the behavior of platelet aggregation and its clinical evaluation in elderly patients with chronic cerebrovascular insufficiency].
    Cajozzo A; Abbadessa V; Musso M; Iannitto E
    Minerva Med; 1983 Jul; 74(28-29):1727-31. PubMed ID: 6346139
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Long-term medical treatment of acute cerebrovascular disease sequelae (comparison papaverine-piribedil].
    Piccinelli A; Neri G; Agnoli A
    Minerva Med; 1974 Nov; 65(80):4199-213. PubMed ID: 4610451
    [No Abstract]   [Full Text] [Related]  

  • 4. [Use of buflomedil in the treatment of obliterative arteriopathies of the lower extremities. Clinical and functional study].
    Cospite M; Ferrara F; Milio G; Meli F
    Clin Ter; 1984 Apr; 109(2):127-35. PubMed ID: 6234122
    [No Abstract]   [Full Text] [Related]  

  • 5. [Therapy of vertigo and tinnitus using sulpirid].
    Conrad B; Aschoff JC
    Nervenarzt; 1973 Jan; 44(1):41-3. PubMed ID: 4687742
    [No Abstract]   [Full Text] [Related]  

  • 6. [Vincamine in the treatment of cerebral circulatory insufficiency in old age].
    Turrisi E; D'Alise R; Mea A; Vitagliano A
    Minerva Cardioangiol; 1975 Jan; 23(1):20-32. PubMed ID: 1143645
    [No Abstract]   [Full Text] [Related]  

  • 7. [Study and evaluation of patients with obliterating arteriopathy of the lower limbs: use of isokinetics to analyze muscular strength and fatigue].
    Demonty B; Detaille V; Pasquier AY
    Ann Readapt Med Phys; 2004 Nov; 47(9):597-603. PubMed ID: 15539066
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Whole blood filterability in chronic cerebrovascular disorders: effects of the use of buflomedil hydrochloride].
    Ciuffetti G; Mercuri M; Lombardini R; Palazzetti D; Rizzo MT; Parnetti L
    Minerva Med; 1989 Nov; 80(11):1237-40. PubMed ID: 2689916
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effects of buflomedil hydrochloride on the rheological properties of the blood in chronic cerebrovascular diseases].
    Lombardini R; Ciuffetti G; Paltriccia R; Scarponi AM; Savastano V; Palazzetti D; Mercuri M; Parnetti L
    Ric Clin Lab; 1989; 19 Suppl 1():117-9. PubMed ID: 2629069
    [No Abstract]   [Full Text] [Related]  

  • 10. [Assessment of betahistine dihydrochloride effectiveness in the treatment of disturbance of balance system, based on analysis of doctors and patients questionnaires results].
    Jurkiewicz D; Kantor I; Usowski J
    Pol Merkur Lekarski; 2006; 21 Suppl 1():3-12. PubMed ID: 17469244
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of memory impairment, vertigo and tinnitus in the elderly with piribedil in an Indian general practice setting.
    Hastak SM
    J Indian Med Assoc; 2003 Aug; 101(8):500-1. PubMed ID: 15071809
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Betahistidine hydrochloride in the treatment of vertebro-basilar insufficiency].
    Botez MI
    Encephale; 1975; 1(3):279-86. PubMed ID: 1227823
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The treatment of cerebrovascular insufficiency. Their evaluation in a double-blind study].
    Feine-Haake G; Neiss A; Weinert W
    MMW Munch Med Wochenschr; 1975 Jun; 117(26):1131-2. PubMed ID: 817147
    [No Abstract]   [Full Text] [Related]  

  • 14. [Problems in the long-term medical treatment of sequelae of acute cerebrovascular diseases. Double-blind studies].
    Agnoli A
    Minerva Med; 1976 May; 67(26):1719-26. PubMed ID: 934526
    [No Abstract]   [Full Text] [Related]  

  • 15. [Eutergin in the treatment of chronic cerebrovascular disturbance patterns (author's transl)].
    Prosenz P
    Aktuelle Gerontol; 1980 Jun; 10(6):245-51. PubMed ID: 6109460
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [MR-Imaging of lower leg muscle perfusion].
    Leppek R; Hoos O; Sattler A; Kohle S; Azzam S; Al Haffar I; Keil B; Ricken P; Klose KJ; Alfke H
    Herz; 2004 Feb; 29(1):32-46. PubMed ID: 14968340
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of PGE-1 in patients suffering from peripheral arterial occlusive disease.
    Milio G; Cospite V; Cospite M
    Minerva Cardioangiol; 2003 Jun; 51(3):311-6. PubMed ID: 12867883
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical and electroencephalographic studies of the effect of nicergoline in cerebrovascular diseases].
    Montanini R; Gasco P; Manfredini G
    Acta Neurol (Napoli); 1973; 28(2):133-49. PubMed ID: 4575428
    [No Abstract]   [Full Text] [Related]  

  • 19. Dialysis clearance of buflomedil in hemodialysed patients.
    Rey E; Moynot A; d'Athis P; Pello JY; Maurel A; Frydman MO; Buisson C; Olive G
    Arzneimittelforschung; 1996 May; 46(5):492-5. PubMed ID: 8737633
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Buflomedil in the treatment of chronic peripheral arterial diseases. Case contribution].
    Visconti W; Grillo N
    Minerva Med; 1985 May; 76(19-20):945-53. PubMed ID: 3158842
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.